These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34494673)

  • 1. Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testis.
    Reda A; Veys K; Kadam P; Taranta A; Rega LR; Goffredo BM; Camps C; Besouw M; Cyr D; Albersen M; Spiessens C; de Wever L; Hamer R; Janssen MCH; D'Hauwers K; Wetzels A; Monnens L; van den Heuvel L; Goossens E; Levtchenko E
    J Inherit Metab Dis; 2021 Nov; 44(6):1393-1408. PubMed ID: 34494673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying nonobstructive azoospermia in cystinosis: histologic examination of testes and epididymis and sperm analysis in a Ctns⁻/⁻ mouse model.
    Besouw MT; van Pelt AM; Gaide Chevronnay HP; Courtoy PJ; Pastore A; Goossens E; Devuyst O; Antignac C; Levtchenko EN
    Fertil Steril; 2012 Jul; 98(1):162-5. PubMed ID: 22578532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility status in male cystinosis patients treated with cysteamine.
    Besouw MT; Kremer JA; Janssen MC; Levtchenko EN
    Fertil Steril; 2010 Apr; 93(6):1880-3. PubMed ID: 19217094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility in Cystinosis.
    Reda A; Veys K; Besouw M
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.
    Papizh S; Serzhanova V; Filatova A; Skoblov M; Tabakov V; van den Heuvel L; Levtchenko E; Prikhodina L
    BMC Nephrol; 2019 Oct; 20(1):400. PubMed ID: 31672123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G; Williams C; Bernardini I; Gahl WA
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.
    Hollywood JA; Przepiorski A; D'Souza RF; Sreebhavan S; Wolvetang EJ; Harrison PT; Davidson AJ; Holm TM
    J Am Soc Nephrol; 2020 May; 31(5):962-982. PubMed ID: 32198276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
    Sonies BC; Almajid P; Kleta R; Bernardini I; Gahl WA
    Medicine (Baltimore); 2005 May; 84(3):137-146. PubMed ID: 15879904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystinosis in adults: A systemic disease].
    Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
    Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular function in males with infantile nephropathic cystinosis.
    Rohayem J; Haffner D; Cremers JF; Huss S; Wistuba J; Weitzel D; Kliesch S; Hohenfellner K
    Hum Reprod; 2021 Apr; 36(5):1191-1204. PubMed ID: 33822926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
    Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
    Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
    Gahl WA; Balog JZ; Kleta R
    Ann Intern Med; 2007 Aug; 147(4):242-50. PubMed ID: 17709758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.
    Hector E; Cairns D; Michael Wall G
    Orphanet J Rare Dis; 2022 Jun; 17(1):231. PubMed ID: 35710564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood and illness experiences of adults with cystinosis.
    Beinart N; Hackett RA; Graham CD; Weinman J; Ostermann M
    Ren Fail; 2015 Jun; 37(5):835-9. PubMed ID: 25715639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of nephropathic cystinosis with cysteamine.
    Kleta R; Gahl WA
    Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
    Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
    Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
    Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
    J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephropathic cystinosis: an update on genetic conditioning.
    Topaloglu R
    Pediatr Nephrol; 2021 Jun; 36(6):1347-1352. PubMed ID: 32564281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.